MT1E and esophageal cancer: The expression of MT2A, MT1E and MT1X in esophageal cancer patients and normal controls was detected by TCGA database, and it was found that the expression of MT2A, MT1E and MT1X in esophageal cancer patients was significantly reduced, which was associated with poor prognosis.